|
gptkbp:instance_of
|
gptkb:pharmaceuticals
gptkb:Company
|
|
gptkbp:acquisition
|
Medi Gene AG (2018)
|
|
gptkbp:advertising
|
gptkb:Ms._Yuki_Tanaka
gptkb:Mr._Kenji_Sato
|
|
gptkbp:annual_report
|
published yearly
|
|
gptkbp:awards
|
Best Workplaces 2021
|
|
gptkbp:ceo
|
gptkb:Haruo_Naito
|
|
gptkbp:clinical_trial
|
ongoing
Phase II
completed
Phase III
ongoing studies
Phase I
future studies
|
|
gptkbp:collaboration
|
academic institutions
|
|
gptkbp:community_engagement
|
health education programs
|
|
gptkbp:conducts_research_on
|
gptkb:Dr._Takashi_Yamamoto
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:focus
|
neurology
oncology
women's health
|
|
gptkbp:founded
|
1941
|
|
gptkbp:founder
|
gptkb:Toyoharu_Eisai
|
|
gptkbp:global_presence
|
over 30 countries
|
|
gptkbp:headquarters
|
gptkb:Tokyo,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Eisai Co., Ltd.
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
Pharmaceuticals
|
|
gptkbp:innovation
|
drug development
|
|
gptkbp:invention
|
numerous
|
|
gptkbp:investment
|
R& D funding
|
|
gptkbp:market
|
global
|
|
gptkbp:partnership
|
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Daiichi_Sankyo
Eisai and Amgen
Eisai and Merck
Eisai and Takeda
|
|
gptkbp:philanthropy
|
Eisai Co., Ltd. Foundation
|
|
gptkbp:products
|
Prescription drugs
medications
|
|
gptkbp:research_and_development
|
gptkb:neurodegenerative_diseases
cancer treatments
epilepsy treatments
|
|
gptkbp:research_areas
|
oncology
gastroenterology
CNS disorders
|
|
gptkbp:research_focus
|
gptkb:Oncology
gptkb:neurodegenerative_diseases
biologics
pain management
small molecules
novel therapies
|
|
gptkbp:revenue
|
$4.5 billion (2020)
|
|
gptkbp:stock_exchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:strategy
|
collaborative research
market penetration
expansion in Asia
|
|
gptkbp:subsidiaries
|
gptkb:Eisai_Europe_Ltd.
gptkb:Eisai_Inc.
|
|
gptkbp:sustainability
|
environmental initiatives
|
|
gptkbp:website
|
www.eisai.com
|
|
gptkbp:bfsParent
|
gptkb:Medi_Gene_AG
gptkb:Alexion_Pharmaceuticals
gptkb:Eisai
gptkb:Daiichi_Sankyo
gptkb:Eli_Lilly_and_Company
|
|
gptkbp:bfsLayer
|
5
|